Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 5800-5899

5800. M. Lytinas, D. Kempuraj, M. Huang, K. Kandere, W. Boucher, R. Letourneau, S. Jeudy, K. Fitzgerald, K. Spear, A. Athanasiou, T.C. Theoharides, “Azelastine’s inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine,” Allergy Asthma Proc. 23(January-February 2002):45-51; D. Kempuraj, M. Huang, K. Kandere, W. Boucher, R. Letourneau, S. Jeudy, K. Fitzgerald, K. Spear, A. Athanasiou, T.C. Theoharides, “Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells,” Ann. Allergy Asthma Immunol. 88(May 2002):501-506.

5801. L.C. Bock, L.C. Griffin, J.A. Latham, E.H. Vermaas, J.J. Toole, “Selection of single-stranded DNA molecules that bind and inhibit human thrombin,” Nature 355(6 February 1992):564-566; L.C. Griffin, G.F. Tidmarsh, L.C. Bock, J.J. Toole, L.L. Leung, “In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits,” Blood 81(15 June 1993):3271-3276; J.A. Latham, R. Johnson, J.J. Toole, “The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2’-deoxyuridine,” Nucleic Acids Res. 22(25 July 1994):2817-2822.

5802. F. Bracht, K. Schror, “Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro,” Biochem. Biophys. Res. Commun. 200(29 April 1994):933-937; F. Bracht, K. Schror, “Isolation and functional characterization of DNA-derived aptamers that act as thrombin inhibitors in human platelets and coagulation assays,” Agents Actions Suppl. 45(1995):315-322.

5803. A. DeAnda Jr., S.E. Coutre, M.R. Moon, C.M. Vial, L.C. Griffin, V.S. Law, M. Komeda, L.L. Leung, D.C. Miller, “Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass,” Ann. Thorac. Surg. 58(August 1994):344-350.

5804. D.M. Tasset, M.F. Kubik, W. Steiner, “Oligonucleotide inhibitors of human thrombin that bind distinct epitopes,” J. Mol. Biol. 272(10 October 1997):688-698.

5805. C.P. Rusconi, A. Yeh, H.K. Lyerly, J.H. Lawson, B.A. Sullenger, “Blocking the initiation of coagulation by RNA aptamers to factor VIIa,” Thromb. Haemost. 84(November 2000):841-848; R. White, C. Rusconi, E. Scardino, A. Wolberg, J. Lawson, M. Hoffman, B. Sullenger, “Generation of species cross-reactive aptamers using ‘toggle’ SELEX,” Mol. Ther. 4(December 2001):567-573; C.P. Rusconi, E. Scardino, J. Layzer, G.A. Pitoc, T.L. Ortel, D. Monroe, B.A. Sullenger, “RNA aptamers as reversible antagonists of coagulation factor IXa,” Nature 419(5 September 2002):90-94, 23-24 (comment).

5806. M.A. Boncler, M. Koziolkiewicz, C. Watala, “Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin,” Thromb. Res. 104(1 November 2001):215-222.

5807. S.W. Hall, C.S. Gibbs, L.L. Leung, “Identification of critical residues on thrombin mediating its interaction with fibrin,” Thromb. Haemost. 86(December 2001):1466-1474.

5808. Larry Gold, Barry Polisky, Olke Uhlenbeck, Michael Yarus, “Diversity of oligonucleotide functions,” Annu. Rev. Biochem. 64(1995):763-797.

5809. Brian J. Hicke, Andrew W. Stephens, “Escort aptamers: a delivery service for diagnosis and therapy,” J. Clin. Invest. 106(October 2000):923-928;

5810. Rebekah R. White, Bruce A. Sullenger, Christopher P. Rusconi, “Developing aptamers into therapeutics,” J. Clin. Invest. 106(October 2000):929-934;

5811. M. Gursel, S. Tunca, M. Ozkan, G. Ozcengiz, G. Alaeddinoglu, “Immunoadjuvant action of plasmid DNA in liposomes,” Vaccine 17(17 March 1999):1376-1383.

5812. G.M. Deng, I.M. Nilsson, M. Verdrengh, L.V. Collins, A. Tarkowski, “Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis,” Nat. Med. 5(June 1999):702-705.

5813. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira, “A Toll-like receptor recognizes bacterial DNA,” Nature 408(7 December 2000):740-745, 659-660 (comment); Nature 409(1 February 2001):646 (erratum).

5814. A. Pertovaara, “Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies,” Prog. Neurobiol. 40(June 1993):691-709.

5815. M.W. Decker, P. Curzon, M.W. Holladay, A.L. Nikkel, R.S. Bitner, A.W. Bannon, D.L. Donnelly-Roberts, P.S. Puttfarcken, T.A. Kuntzweiler, C.A. Briggs, M. Williams, S.P. Arneric, “The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594,” J. Physiol. Paris 92(June-August 1998):221-224.

5816. A.R. Santos, R.O. De Campos, O.G. Miguel, V. Cechinel-Filho, R.A. Yunes, J.B. Calixto, “The involvement of K+ channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester,” Eur. J. Pharmacol. 379(20 August 1999):7-17.

5817. P.J. Cabot, “Immune-derived opioids and peripheral antinociception,” Clin. Exp. Pharmacol. Physiol. 28(March 2001):230-232.

5818. V. Morisset, J. Ahluwalia, I. Nagy, L. Urban, “Possible mechanisms of cannabinoid-induced antinociception in the spinal cord,” Eur. J. Pharmacol. 429(19 October 2001):93-100.

5819. W. Riedel, G. Neeck, “Nociception, pain, and antinociception: current concepts,” Z. Rheumatol. 60(December 2001):404-415.

5820. N.V. Beloborodova, G.A. Osipov, “Homeostasis of small molecules originating from microbes and its role in microbial relations with the host,” Vestn. Ross. Akad. Med. Nauk. 7(1999):25-31. In Russian.

5821. C. Svensson, M. Andersson, L. Greiff, C.G. Persson, “Nasal mucosal endorgan hyperresponsiveness,” Am. J. Rhinol. 12(January-February 1998):37-43.

5822. S.J. James, M. Pogribna, B.J. Miller, B. Bolon, L. Muskhelishvili, “Characterization of cellular response to silicone implants in rats: implications for foreign-body carcinogenesis,” Biomaterials 18(May 1997):667-675.

5823. R.J. Langford, J.W. Frame, “Tissue changes adjacent to titanium plates in patients,” J. Craniomaxillofac. Surg. 30(April 2002):103-107; J. Craniomaxillofac. Surg. 30(December 2002):373 (erratum).

5824. N. McFadden, T. Lyberg, A. Hensten-Pettersen, “Aluminum-induced granulomas in a tattoo,” J. Am. Acad. Dermatol. 20(May 1989):903-908.

5825. R.J. Johnson, “The design of cellulosic based membranes that do not activate complement,” Med. Prog. Technol. 15(1989):77-81; J.R. Frautschi, R.C. Eberhart, J.A. Hubbell, B.D. Clark, J.A. Gelfand, “Alkylation of cellulosic membranes results in reduced complement activation,” J. Biomater. Sci. Polym. Ed. 7(1996):707-714; S.K. Bowry, T.H. Rintelen, “Synthetically modified cellulose (SMC): a cellulosic hemodialysis membrane with minimized complement activation,” ASAIO J. 44(September-October 1998):M579-M583.

5826. I. Mayers, D. Johnson, “The nonspecific inflammatory response to injury,” Can. J. Anaesth. 45(September 1998):871-879.

5827. Y.T. Konttinen, J.E. Michelsson, E. Tolvanen, V. Bergroth, “Primary inflammatory reaction in synovial fluid and tissue in rabbit immobilization osteoarthritis,” Clin. Orthop. 260(November 1990):280-286.

5828. K. Buchmann, “Immune mechanisms in fish skin against monogeneans – a model,” Folia Parasitol. (Praha) 46(1999):1-9.

5829. J. Hoher, H.D. Moller, F.H. Fu, “Bone tunnel enlargement after anterior cruciate ligament reconstruction: fact or fiction?” Knee Surg. Sports Traumatol. Arthrosc. 6(1998):231-240.

5830. Ho Choi, Cheol Joo Lee, Kwang Deok Moon, Young Jin Kim, Joon Kyu Kang, Jun Wha Hong, Kyoung Soo Jee, Man Jung Han, Sang Ho Cho, “Angiogenic response to transmyocardial mechanical revascularization (TMMR) with polymer myocardial stent,” Korean Thorac. Cardiovasc. Surg. 33(2000):494-501; V.F. Chu, A. Giaid, J.Q. Kuang, A.N. McGinn, C.M. Li, M.P. Pelletier, R.C. Chiu, “Thoracic Surgery Directors Association Award. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures,” Ann. Thorac. Surg. 68(August 1999):301-307, 307-8 (discussion); V. Chu, J. Kuang, A. McGinn, A. Giaid, S. Korkola, R.C. Chiu, “Angiogenic response induced by mechanical transmyocardial revascularization,” J. Thorac. Cardiovasc. Surg. 118(November 1999):849-856.

5831. T. Saito, M.P. Pelletier, H. Shennib, A. Giaid, “Nitric oxide system in needle-induced transmyocardial revascularization,” Ann. Thorac. Surg. 72(July 2001):129-136.

5832. V.A. Keszei, “Diffuse lamellar keratitis associated with iritis 10 months after laser in situ keratomileusis,” J. Cataract Refract. Surg. 27(July 2001):1126-1127.

5833. N. van der Laan, L. de Leij, H.J. ten Duis, “Local cellular inflammation as a result of elective standardized vascular surgery,” Acta Histochem. 103(April 2001):139-149.

5834. T.W. Hesterberg, W.C. Miller, E.E. McConnell, J. Chevalier, J.G. Hadley, D.M. Bernstein, P. Thevenaz, R. Anderson, “Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats,” Fundam. Appl. Toxicol. 20(May 1993):464-476.

5835. Walter Magerl, “Technical Corner: Neural mechanisms of itch sensation,” IASP Newsletter, September/October 1996;

5836. R.G. Bickford, “Experiments relating to the itch sensation, its peripheral mechanism and central pathways,” Clin. Sci. 3(1938):377–386.

5837. R.H. LaMotte, D.A. Simone, T.K. Baumann, C.N. Shain, M. Alreja, “Hypothesis for novel classes of chemoreceptors mediating chemogenic pain and itch,” in R. Dubner, G.F. Gebhart, M.R. Bond, eds., Proceedings of the Vth World Congress on Pain, Elsevier, Amsterdam, 1988, pp. 529–535.

5838. G. Heyer, F.J. Ulmer, J. Schmitz, H.O. Handwerker, “Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls,” Acta Derm. Venereol. (Stockh.) 75(1995):348–352.

5839. “Phytis Diamond Stents,”

5840. William Burns, Thomas R.B. Mitchell, M. Anthony McKervey, John J. Rooney, George Ferguson, Paul Roberts, “Gas-phase reactions on platinum. Synthesis and crystal structure of anti-tetramantane, a large diamondoid fragment,” J. Chem. Soc. Chem. Commun. (1976):893-895; William Burns, M. Anthony McKervey, Thomas R.B. Mitchell, John J. Rooney, “A new approach to the synthesis of diamondoid hydrocarbons: synthesis of anti-tetramantane,” J. Am. Chem. Soc. 100(1978):906-911.

5841. J.E. Dahl, S.G. Liu, R.M. Carlson, “Isolation and structure of higher diamondoids, nanometer-sized diamond molecules,” ScienceExpress (29 November 2002); or

5842. A.P. Marchand, “Diamondoid hydrocarbons – Delving into Nature’s bounty,” ScienceExpress (29 November 2002); or

5843. R.T. Sanderson, Chemical Bonds and Bond Energy, Academic Press, New York, 1976. See also: R.T. Sanderson, J. Am. Chem. Soc. 105(1983):2259.

5844. M. Blank, E. Findl, eds., Mechanistic Approaches to Interactions of Electric and Electromagnetic Fields with Living Systems, Plenum, New York, 1987.

5845. B.N. Ames, J. McCann, E. Yamasaki, “Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test,” Mutat. Res. 31(December 1975):347-364; B.N. Ames, “Identifying environmental chemicals causing mutations and cancer,” Science 204(11 May 1979):587-593.

5846. R. Forster, in D.F. Williams, ed., Techniques of Biocompatibility Testing, Vol. II, CRC Press, Boca Raton, FL, 1986, p. 137.

5847. K. Merritt, S.A. Brown, “Tissue reaction and metal sensitivity. An animal study,” Acta Orthop. Scand. 51(June 1980):403-411.

5848. K. Merritt, in D.F. Williams, ed., Techniques of Biocompatibility Testing, Vol. II, CRC Press, Boca Raton, FL, 1986, p. 123.

5849. R.E. Wilsnack, “Quantitative cell culture biocompatibility testing of medical devices and correlation to animal tests,” Biomater. Med. Devices Artif. Organs 4(1976):235-261.

5850. H.J. Johnson, S.J. Northup, in S.A. Brown, ed., Cell-Culture Test Methods, ASTM STP 810, American Society for Testing and Materials, Philadelphia, PA, 1983, p. 25.

5851. A. Wieslander, A. Magnusson, P. Kjellstrand, “Use of cell culture to predict toxicity of solid materials in blood contact,” Biomater. Artif. Cells Artif. Organs 18(1990):367-374.

5852. D.D. Lindholm, E. Klein, J.K. Smith, “Relative thrombogenicity of blood interface material: method and results,” Proc. Clin. Dial. Transplant. Forum 3(1973):39-45.

5853. R.G. Mason, “Blood compatibility of biomaterials: evaluation of a simple screening test,” Biomater. Med. Devices Artif. Organs 1(1973):131-139; R.G. Mason, B.A. Shinoda, W.C. Blackwelder, R.C. Elston, “Blood compatibility of biomaterials: further evaluation of the Lindholm test,” Biomater. Med. Devices Artif. Organs 2(1974):21-30.

5854. E.F. Grabowski, P. Didisheim, J.C. Lewis, J.T. Franta, J.Q. Stropp, “Platelet adhesion to foreign surfaces under controlled conditions of whole blood flow: human vs rabbit, dog, calf, sheep, pig, macaque, and baboon,” Trans. Am. Soc. Artif. Intern. Organs 23(1977):141-151.

5855. G.A. Skarja, R.L. Kinlough-Rathbone, D.W. Perry, F.D. Rubens, J.L. Brash, “A cone-and-plate device for the investigation of platelet biomaterial interactions,” J. Biomed. Mater. Res. 34(15 March 1997):427-438.

5856. L.C. Anderson, H.C. Hughes, in A.F. von Recum, ed., Handbook of Biomaterials Evaluation, Macmillan, New York, 1986, p. 255.

5857. R.S. Wortman, K. Merritt, S.A. Brown, “The use of the mouse peritoneal cavity for screening for biocompatibility of polymers,” Biomater. Med. Devices Artif. Organs 11(1983):103-114.

5858. A.B. Ferguson Jr., P.G. Laing, E.S. Hodge, "The ionization of metal implants in living tissues," J. Bone Joint Surg. 42A(January 1960):77-90.

5859. D.M. Nunamaker, J. Black, Trans. Orthop. Res. Soc. 3(1978):160.

5860. D.P. Rivero, J. Fox, A.K. Skipor, R.M. Urban, J.O. Galante, “Calcium phosphate-coated porous titanium implants for enhanced skeletal fixation,” J. Biomed. Mater. Res. 22(March 1988):191-201.

5861. A. Berzins, D.R. Sumner, T.M. Turner, R. Natarajan, “Effects of fixation technique on displacement incompatibilities at the bone-implant interface in cementless total knee replacement in a canine model,” J. Appl. Biomater. 5(Winter 1994):349-352.

5862. B. Kusserow, R. Larrow, J. Nichols, “Observations concerning prosthesis-induced thromboembolic phenomena made with an in vivo embolus test system,” Trans. Am. Soc. Artif. Intern. Organs 16(1970):58-62.

5863. V.L. Gott, A. Furuse, “Antithrombogenic surfaces, classification and in vivo evaluation,” Fed. Proc. 30(September-October 1971):1679-1687.

5864. A.F. von Recum, H. Imamura, P.S. Freed PS, Kantrowitz A, Chen ST, Ekstrom ME, Baechler CA, Barnhart MI. Biocompatibility tests of components of an implantable cardiac assist device. J Biomed Mater Res 1978 Sep;12(5):743-65

5865. S. Brody, Bioenergetics and Growth, with Special Reference to the Efficiency Complex in Domestic Animals, Reinhold, New York, 1945, p. 352.

5866. J.L. Adcock, Professor of Chemistry;

5867. Andrei A. Gakh, Albert A. Tuinman, J.L. Adcock, Richard A. Sachleben, Robert N. Compton, “Selective synthesis and structure determination of C60F48,” J. Amer. Chem. Soc. 116(1994):819-820; “Chemists produce single C60F48 fullerene isomer,” Chem. & Eng. News, 7 February 1994; Albert A. Tuinman, Andrei A. Gakh, J.L. Adcock, Robert N. Compton, “Hyper-fluorination of C60; Cracking the sphere,” J. Amer. Chem. Soc. 115(1993):5885-5886; “Science/Technology Concentrates: Hyperfluorination cracks C60 cage,” Chem. & Eng. News, 71(5 July 1993):19; P.J. Benning, T.R. Ohno, J.H. Weaver, P. Mukherjee, J.L. Adcock, R.N. Compton, B.I. Dunlap, “Electronic structure of highly fluorinated C60,” Phys. Rev. B 47(1993):1589-1592; A.A. Tuinman, P. Mukherjee, J.L. Adcock, R.L. Hettich, R.N. Compton, “Characterization and stability of highly fluorinated fullerenes,” J. Phys. Chem. 96(1992):7584-7589.

5868. Benjamin T. King, Assistant Professor, Organic Chemistry;

5869. D.F. Williams, ed., The Williams Dictionary of Biomaterials, Liverpool University Press, Liverpool, U.K., 1999;

5870. D.F. Williams, J. Black, P.J. Doherty, Second Consensus Conference, Definitions in Biomaterials, in Chester, England; in P.J. Doherty, R.L. Williams, D.F. Williams, A.J.C. Lee, eds., Biomaterial-Tissue Interfaces. Advances in Biomaterials, Vol. 10, Elsevier, Amsterdam, 1992, p. 525.

5871. K. Gekko, S.N. Timasheff, “Thermodynamic and kinetic examination of protein stabilization by glycerol,” Biochemistry 20(4 August 1981):4677-4686; K. Gekko, S.N. Timasheff, “Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures,” Biochemistry 20(4 August 1981):4667-4676.

5872. A. Naji, “Induction of tolerance by intrathymic inoculation of alloantigen,” Curr. Opin. Immunol. 8(October 1996):704-709; C.F. Barker, A.M. Posselt, J.S. Odorico, J.F. Markmann, A. Naji, “Intrathymic transplantation as a model for tolerance,” Adv. Nephrol. Necker Hosp. 22(1993):387-400.

5873. S.K. Salgar, R. Shapiro, F. Dodson, R. Corry, K. McCurry, A. Zeevi, S. Pham, K. Abu-Elmagd, J. Reyes, M. Jordan, R. Keenan, B. Griffith, T. Sesky, L. Ostrowski, T.E. Starzl, J.J. Fung, A.S. Rao, “Infusion of donor leukocytes to induce tolerance in organ allograft recipients,” J. Leukoc. Biol. 66(August 1999):310-314; S.M. Pham, A.S. Rao, A. Zeevi, K.R. McCurry, R.J. Keenan, J.D. Vega, R.L. Kormos, B.G. Hattler, J.J. Fung, T.E. Starzl, B.P. Griffith, “Effects of donor bone marrow infusion in clinical lung transplantation,” Ann. Thorac. Surg. 69(February 2000):345-350; T.E. Starzl, “History of clinical transplantation,” World J. Surg. 24(July 2000):759-782.

5874. N. Tsao, T.Y. Luh, C.K. Chou, J.J. Wu, Y.S. Lin, H.Y. Lei, “Inhibition of group A streptococcus infection by carboxyfullerene,” Antimicrob. Agents Chemother. 45(June 2001):1788-1793;

5875. N. Tsao, T.Y. Luh, C.K. Chou, T.Y. Chang, J.J. Wu, C.C. Liu, H.Y. Lei, “In vitro action of carboxyfullerene,” J. Antimicrob. Chemother. 49(April 2002):641-649.

5876. N. Tsao, C.M. Wu, H.P. Hsu, C.C. Liu, T.Y. Luh, C.K. Chou, H.Y. Lei, “Inhibition of the increased permeability of blood-brain barrier in Escherichia coli-induced meningitis by carboxyfullerene,” Fullerene Sci. Technol. 9(2001):307-320.

5877. F. Pellarini, D. Pantarotto, T. Da Ros, A. Giangaspero, A. Tossi, M. Prato, “A novel [60]fullerene amino acid for use in solid-phase peptide synthesis,” Org. Lett. 3(14 June 2001):1845-1848.

5878. C. Fumelli, A. Marconi, S. Salvioli, E. Straface, W. Malorni, A.M. Offidani, R. Pellicciari, G. Schettini, A. Giannetti, D. Monti, C. Franceschi, C. Pincelli, “Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis,” J. Invest. Dermatol. 115(November 2000):835-841.

5879. D. Monti, L. Moretti, S. Salvioli, E. Straface, W. Malorni, R. Pellicciari, G. Schettini, M. Bisaglia, C. Pincelli, C. Fumelli, M. Bonafe, C. Franceschi, “C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells,” Biochem. Biophys. Res. Commun. 277(2 November 2000):711-717.

5880. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B.F. Erlanger, P. Seta, C. Larroque, “Cellular localisation of a water-soluble fullerene derivative,” Biochem. Biophys. Res. Commun. 294(31 May 2002):116-119.

5881. S.A. Belinsky, S.S. Snow, K.J. Nikula, G.L. Finch, C.S. Tellez, W.A. Palmisano, “Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens,” Carcinogenesis 23(February 2002):335-339.

5882. M. Lonnberg, J. Carlsson, “Quantitative detection in the attomole range for immunochromatographic tests by means of a flatbed scanner,” Anal. Biochem. 293(15 June 2001):224-231.

5883. L.L. Greenwell, T. Moreno, T.P. Jones, R.J. Richards, “Particle-induced oxidative damage is ameliorated by pulmonary antioxidants,” Free Radic. Biol. Med. 32(1 May 2002):898-905.

5884. M.R. Bliss, “Hyperaemia,” J. Tissue Viability 8(October 1998):4-13.

5885. J.M. Pique, B.J. Whittle, J.V. Esplugues, “The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation,” Eur. J. Pharmacol. 174(19 December 1989):293-296; C. Baylis, C. Qiu, “Importance of nitric oxide in the control of renal hemodynamics,” Kidney Int. 49(June 1996):1727-1731; M. Feletou, E. Bonnardel, E. Canet, “Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide,” Br. J. Pharmacol. 118(July 1996):1371-1376; C. Melot, F. Vermeulen, M. Maggiorini, E. Gilbert, R. Naeije, “Site of pulmonary vasodilation by inhaled nitric oxide in microembolic lung injury,” Am. J. Respir. Crit. Care Med. 156(July 1997):75-85;; M. Oda, J.Y. Han, H. Yokomori, “Local regulators of hepatic sinusoidal microcirculation: recent advances,” Clin. Hemorheol. Microcirc. 23(2000):85-94; Z. Ashley, B. Jugg, R.F. Brown, C.E. Kenward, J. Platt, P. Rice, F.M. Harban, “Effects of inhaled nitric oxide on the anesthetized, mechanically ventilated, large white pig,” Inhal. Toxicol. 14(November 2002):1175-1185.

5886. A.R. Butler, I.L. Megson, P.G. Wright, “Diffusion of nitric oxide and scavenging by blood in the vasculature,” Biochim. Biophys. Acta 1425(16 September 1998):168-176; S. Calatayud, B. Beltran, J. Brines, S. Moncada, J.V. Esplugues, “Foetal erythrocytes exhibit an increased ability to scavenge for nitric oxide,” Eur. J. Pharmacol. 347(24 April 1998):363-366; L. Olmos, J.V. Mombouli, N. Wasserstrum, P.M. Vanhoutte, “Ability of sickle cells to scavenge endothelium-derived nitric oxide is reduced,” Acta Pharmacol. Sin. 23(November 2002):967-973; K.T. Huang, T.H. Han, D.R. Hyduke, M.W. Vaughn, H. Van Herle, T.W. Hein, C. Zhang, L. Kuo, J.C. Liao, “Modulation of nitric oxide bioavailability by erythrocytes,” Proc. Natl. Acad. Sci. (USA) 98(25 September 2001):11771-11776;

5887. J.C. Liao, T.W. Hein, M.W. Vaughn, K.T. Huang, L. Kuo, “Intravascular flow decreases erythrocyte consumption of nitric oxide,” Proc. Natl. Acad. Sci. (USA) 96(20 July 1999):8757-8761;

5888. R.P. Patel, “Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes,” Free Radic. Biol. Med. 28(15 May 2000):1518-1525.

5889. L. Raij, E. Jaimes, D. del Castillo, J. Guerra, G. Westberg, “Pathophysiology of the vascular wall: the role of nitric oxide in renal disease,” Prostaglandins Leukot. Essent. Fatty Acids 54(January 1996):53-58; M. Ziche, L. Morbidelli, “Nitric oxide and angiogenesis,” J. Neurooncol. 50(October-November 2000):139-148; S.B. Abramson, A.R. Amin, R.M. Clancy, M. Attur, “The role of nitric oxide in tissue destruction,” Best Pract. Res. Clin. Rheumatol. 15(December 2001):831-845.

5890. G. Burnstock, V. Ralevic, “New insights into the local regulation of blood flow by perivascular nerves and endothelium,” Br. J. Plast. Surg. 47(December 1994):527-543; C.L. Speyer, C.P. Steffes, J.G. Tyburski, J.L. Ram, “Lipopolysaccharide induces relaxation in lung pericytes by an iNOS-independent mechanism,” Am. J. Physiol. Lung Cell Mol. Physiol. 278(May 2000):L880-L887;; R. Zakaria, D.A. Spain, P.D. Harris, R.N. Garrison, “Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions,” Perit. Dial. Int. 22(September-October 2002):593-601.

5891. R. El-Galley, H. Rutland, R. Talic, T. Keane, H. Clark, “Long-term efficacy of sildenafil and tachyphylaxis effect,” J. Urol. 166(September 2001):927-931; M. Fujimura, S. Myou, Y. Kamio, T. Hashimoto, T. Matsuda, “Duration of tachyphylaxis in response to methacholine in healthy non-asthmatic subjects,” Respirology 4(March 1999):47-51; E. Galligioni, D. Favaro, M. Santarosa, M. Quaia, A. Spada, A. Freschi, D. Alberti, “Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response,” Clin. Cancer Res. 1(May 1995):493-499.

5892. Peter L. Williams, Roger Warwick, Mary Dyson, Lawrence H. Bannister, eds., Gray’s Anatomy, Thirty-Seventh Edition, Churchill Livingstone, New York, 1989.

5893. Arthur C. Guyton, Anatomy and Physiology, Saunders College Publishing, New York, 1985.

5894. J.R. Young, “The swollen leg,” Am. Fam. Physician 15(January 1977):163-173.

5895. P.F. Sauer, A.J. Bueschen, L.O. Vasconez, “Lymphedema of the penis and scrotum,” Clin. Plast. Surg. 15(July 1988):507-511.

5896. D.S. Folse, A. Ewert, “Edema resulting from experimental filariasis,” Lymphology 21(December 1988):244-247.

5897. T. Case, B. Leis, M. Witte, D. Way, M. Bernas, P. Borgs, C. Crandall, R. Crandall, R. Nagle, S. Jamal, et al, “Vascular abnormalities in experimental and human lymphatic filariasis,” Lymphology 24(December 1991):174-183.

5898. R. Crandall, C. Crandall, T. Doyle, J. Nayar, “Immune responses and chronic lymphedema in experimental filariasis,” Lymphology 26(September 1993):120-127.

5899. D.G. Addiss, K.A. Dimock, M.L. Eberhard, P.J. Lammie, “Clinical, parasitologic, and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis,” J. Infect. Dis. 171(March 1995):755-758.


Last updated on 16 April 2004